Evonik will raise price for Rexim® amino & keto acids in all markets; up to 15% price rise

Evonik to increase price for Rexim® amino & keto acids

Evonik will apply a price increase of up to 15 percent on selected products within the Rexim® pharmaceutical amino and keto acid portfolio. The price increase is a response to rising energy, raw material and freight expenses. It will be effective immediately for all markets.

All existing contracts and supply agreements will be honored.

Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €14.1 billion and earnings (adjusted EBITDA) of €1.9 billion in 2025. The common motivation of the approximately 31,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people’s lives. In all markets. Every day.

The Custom Solutions segment focuses on innovation-driven, tailor-made solutions for customers in specific growth markets. These solutions include additives for coatings, adhesives and sealants, polyurethane foams and lubricants, catalysts, and ingredients for the cosmetics, cleaning and pharmaceutical industries. In 2025, the segment generated sales of €5.4 billion with around 9,500 employees.

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.

Evonik Industries AGRellinghauser Straße 1-1145128 EssenGermany

Supervisory Board Bernd Tönjes, Chairman Executive Board Christian Kullmann, Lauren Kjeldsen, Dr. Claudine Mollenkopf, Michael Rauch, Thomas Wessel

Registered Office is Essen Register Court Essen Local Court Commercial Registry B 19474

Head of Market Communications Health Care